Key result
Depression plus reduced HRV in ACHD linked to ~7-fold higher risk of HF or death.
Why the study?
In adult congenital heart disease, major depressive disorder is a frequent comorbidity, but the prognostic relevance of major depressive disorder and heart rate variability was unknown.
Does major depressive disorder combined with reduced heart rate variability predict adverse clinical outcomes in adults with congenital heart disease?
Cohort (n=171)
No
Does major depressive disorder combined with reduced heart rate variability predict adverse clinical outcomes in adults with congenital heart disease?
In adults with congenital heart disease, the combination of major depressive disorder and reduced heart rate variability strongly predicts heart failure, mortality, arrhythmias, and hospitalization.
Answers are grounded in this paper and cite their sources.
May warrant closer monitoring in ACHD; extends non-congenital MDD-HRV links but leaves practice change open.
In adult congenital heart disease (ACHD), major depressive disorder (MDD) represents a frequent comorbidity. In non-CHD, adverse outcome is predicted by MDD and heart rate variability (HRV), whereas in ACHD their prognostic relevance is unknown. We prospectively evaluated 171 patients (age 35.6 ± 11.4 years; male 42.7%, mean observation time 54.7 ± 14.9 months). Binary regression analysis calculated the association between MDD and HRV. Cox proportional survival analysis estimated their impact on decompensated heart failure and all-cause mortality (HF/death), supraventricular and ventricular tachycardia (SVT/VT), and hospitalization due to unexpected cardiac causes. Exclusively MDD with moderate/severe symptoms showed significantly lower HRV as derived from frequency-domain analysis (Symindex) (p = 0.013). In multivariate Cox regression analysis, patients stratified according to the lower quartile of the Symindex comorbid with MDD (n = 16) exhibited poorer prognosis regarding HF/death (Hazard Ratio (HR): 7.04 (95%CI:(1.87–26.5)), SVT/VT (HR: 4.90 (95%CI:1.74–9.25)) and hospitalization (HR: 3.80 (95%CI:1.36–10.6)). An additional independent predictor was N-terminal pro-B-type natriuretic peptide elevation (p < 0.001), indicating advanced HF and heart disease complexity (p < 0.001). Autonomic nervous system dysfunction measured by altered HRV is considered to be one of the pathways linking MDD and adverse outcomes in cardiac diseases. Our results exceed the existing literature by demonstrating that MDD with decreased HRV is associated with poorer prognosis in ACHD.
No takes yet. Share an insight, caveat, or question.
Westhoff‐Bleck et al. (2021) conducted a cohort in Adult congenital heart disease (n=171). Major depressive disorder with reduced heart rate variability vs. Patients without major depressive disorder or with normal heart rate variability was evaluated on Decompensated heart failure and all-cause mortality (HF/death) (HR 7.04, 95% CI 1.87-26.5). In adults with congenital heart disease, major depressive disorder combined with reduced heart rate variability was associated with a increased risk of heart failure or death.
Synapse has enriched 10 related papers. Consider them for comparative context: